HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Aperta

SettoreFinanza

209.8 3.35

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

202.6

Massimo

210.2

Metriche Chiave

By Trading Economics

Entrata

-34M

71M

Vendite

85M

1.3B

P/E

Media del settore

29.8

22.989

EPS

0.08

Rendimento da dividendi

3.47

Margine di Profitto

5.575

Dipendenti

10,910

EBITDA

57M

338M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+44.01% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

3.47%

4.69%

Utili prossimi

4 ago 2026

Prossima data del' Ex Dividendo

20 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-793M

4.1B

Apertura precedente

206.45

Chiusura precedente

209.8

Notizie sul Sentiment di mercato

By Acuity

50%

50%

157 / 439 Classifica in Finance

ConvaTec Group PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Chi Siamo ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat